AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 125.00
+3.00 (2.46%)
May 29, 2026, 1:53 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 10.74 billion as of May 29, 2026. Its market cap has increased by 151.22% in one year.
Market Cap
10.74B
Enterprise Value
9.70B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
125.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 10.74B, an increase of 110.76%. That is a compound annual growth rate of 29.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 10.74B | -29.90% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 14.79B |
| CHO Pharma | 14.47B |
| TaiMed Biologics | 13.46B |
| EirGenix | 12.76B |
| Ever Supreme Bio Technology | 12.32B |
| Polaris Group | 12.21B |
| Locus Cell | 10.60B |
| Tanvex BioPharma | 10.33B |